Claims
- 1. An isolated polypeptide comprising amino acid residues 23-319 of SEQ ID NO:2.
- 2. The isolated polypeptide of claim 1 wherein the polypeptide comprises SEQ ID NO:2.
- 3. The isolated polypeptide of claim 1 wherein the polypeptide is SEQ ID NO:2.
- 4. The isolated polypeptide of claim 1 wherein the polypeptide further comprises a detectable label.
- 5. The isolated polypeptide of claim 1 wherein the polypeptide further comprises an affinity tag.
- 6. A composition comprising:
an isolated polypeptide comprising amino acid residues 23-319 of SEQ ID NO:2; and a pharmaceutically acceptable carrier.
- 7. The composition of claim 6 wherein composition comprises an oligomerized complex of the polypeptide.
- 8. The composition of claim 7 wherein the oligomerized complex comprises at least one trimer of the polypeptide.
- 9. The composition of claim 7 wherein the polypeptide is a trimer.
REFERENCE TO RELATED APPLICATION
[0001] The present application is a divisional of U.S. patent application Ser. No. 10/012,605, filed Dec. 7, 2001, which claims the benefit of U.S. Patent Application Serial No. 60/254,019, filed Dec. 7, 2000, both of which are herein incorporated by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60254019 |
Dec 2000 |
US |
Divisions (1)
|
Number |
Date |
Country |
Parent |
10012605 |
Dec 2001 |
US |
Child |
10719205 |
Nov 2003 |
US |